The Use and Abuse of Psychotropic Medication in People with Autistic Spectrum Disorder - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

The Use and Abuse of Psychotropic Medication in People with Autistic Spectrum Disorder

Description:

Correct recognition & diagnosis of ASD vital. ... Barnard et al (2002) A systematic review of the use of atypical antipsychotics ... – PowerPoint PPT presentation

Number of Views:124
Avg rating:3.0/5.0
Slides: 23
Provided by: Croc1
Category:

less

Transcript and Presenter's Notes

Title: The Use and Abuse of Psychotropic Medication in People with Autistic Spectrum Disorder


1
The Use and Abuse of Psychotropic Medication in
People with Autistic Spectrum Disorder
  • Dr Juli Crocombe
  • Consultant Psychiatrist
  • Care Principles Ltd
  • Clinical Lecturer Keele University

2
Outline
  • The nature of ASD
  • Implications
  • Psychotropic medication
  • Other medication
  • Comorbid mental illness
  • Troublesome features
  • Challenging Behaviour
  • Prescribing issues

3
The Nature of ASD
  • ASD is a
  • DEVELOPMENTAL DISORDER
  • It is not a mental illness.

4
What Does This Mean?
  • YOU CANNOT TREAT ASD WITH PSYCHOTROPIC
    MEDICATION
  • YOU CAN TREAT
  • - COMORBID MENTAL ILLNESS
  • - TROUBLESOME FEATURES OF ASD inc challenging
    behaviour

5
Implications
  • Correct recognition diagnosis of ASD vital.
  • Correct recognition diagnosis of comorbid
    mental illness essential.
  • Detailed assessment to develop full accurate
    understanding of nature cause of troublesome
    features essential.

6
(No Transcript)
7
Psychotropic Medication
  • Anxiolytics eg diazepam, lorazepam
  • Antipsychotics eg haloperidol, risperidone
  • Antidepressants eg fluoxetine, mirtazapine
  • Mood stabilisers eg lithium, carbamazepine
  • Others

8
Other Drugs
  • Buspirone
  • Propranolol
  • Opioid antagonists
  • Cyproterone
  • Methylphenidate

9
Comorbid Mental Illness
  • PwASD are at increased risk of mental illness of
    all types
  • Treat mental illness in PwASD in same way as
    general population BUT be aware of increased
    likelihood of sensitivity / idiosyncratic
    responses

10
Troublesome Features
  • Anxiety - anxiolytics
  • - antidepressant
  • - buspirone
  • - propranolol
  • Hyperactivity methylphenidate
  • Rituals or stereotypies SSRI
  • Obsessive/compulsive features SSRI
  • Catatonia benzodiazepines

11
Challenging Behaviour is
  • culturally abnormal behaviour(s) of such an
    intensity, frequency or duration, that the
    physical safety of the person or others is likely
    to be placed in serious jeopardy, or behaviour
    which is likely to seriously limit use of, or
    result in the person being denied access to,
    ordinary community facilities.
  • Emerson et al, 1988.

12
Challenging behaviour includes-
  • Physical assault
  • Damage to environment
  • Self-injury
  • Non-compliance
  • Persistent screaming
  • Pica
  • Public masturbation
  • Inappropriate sexual behaviour
  • Recurrent vomiting
  • Aggression
  • Self-injurious behaviour
  • Problematic sexual behaviour

13
Aggression
14
Consider nature of / drive for aggressive
behaviour
  • Explosive/ cyclical/ episodic dyscontrol
  • - carbamazepine
  • Anxiety driven
  • - antidepressant - SSRIs
  • - mirtazapine
  • - antipsychotic - typical
  • - atypical
  • High arousal
  • - b blockers - propranolol

15
Self Injurious Behaviour
16
Consider nature of / drive for self-injurious
behaviours
  • Aggressive act
  • Endorphin model of self-injury
  • - opioid antagonists - naloxone
  • - naltrexone
  • Mood stabilisers - lithium

17
Problematic Sexual Behaviour
18
Antilibidinal Drugs
  • Neuroleptics benperidol
  • Antiandrogens cyproterone acetate
  • SSRIs - fluoxetine

19
Prescribing Issues
  • Capacity and consent
  • Compliance
  • Pharmacokinetics
  • Drug interactions
  • Idiosyncratic reactions
  • Side effects

20
Summary
  • ASD is not a mental illness
  • There is no psychotropic medication to treat
    ASD per se
  • Psychotropic medication is used to treat
  • - comorbid mental illness
  • - troublesome features
  • - Challenging Behaviour
  • Know what you are treating and tailor medication
    accordingly
  • Remember, psychotropic medication can cause side
    effects and produce problems as well as benefits

21
Summary
  • Choose medication only after having considered
    and addressed the following
  • - environmental issues
  • - communication issues
  • - physical illness
  • - mental illness
  • Review the appropriateness of medication
    regularly, remembering it can make things worse.
  • Dont forget, psychotropic medication is only one
    approach to improving the quality of life for
    PwASD

22
References
  • Barnard et al (2002) A systematic review of the
    use of atypical antipsychotics in autism Journal
    of Psychopharmacology 16(1) 93-101Ashcroft et al
    (2001) Are antipsychotic drugs the right
    treatment for challenging behaviour in learning
    disability? the place of a randomised trial
    Journal of Medical Ethics 27338-343
  • Robertson et al (2000) Receipt of psychotropic
    medication by people with intellectual disability
    in residential settings JIDR 44(6) 666-676
  • Jenkins R (2000) Use of psychotropic medication
    in people with a learning disability BJNursing
    9(13) 844-850
  • Brylewski Duggan (1999) Antipsychotic
    medication for challenging behaviour in people
    with intellectual disability a systematic review
    of randomised controlled trials JIDR 43(5)
    360-371
  • Santosh Baird (1999) Psychopharmacotherapy in
    children and adults with intellectual disability
    The Lancet 354 233-242
  • Suresh (1998) As required neuroleptics Have
    these drugs a place in the management of
    challenging behaviour in intellectual disability?
    JIDR 42(6) 500-504
  • Branford (1996) A review of antipsychotic drugs
    prescribed for people with learning disabilities
    who live in Leicestershire JIDR 40(4) 358-368
  • Kiernan et al (1995) The use of anti-psychotic
    drugs with adults with learning disabilities and
    challenging behaviour JIDR 39(4) 263-274
Write a Comment
User Comments (0)
About PowerShow.com